title: Oral and topical spironolactone therapies in skin androgenization.
abstract: The most important clinical studies using spironolactone as an antiandrogen drug either per os or topically are referred. Menstrual disturbances very often occur during SP treatments thus limiting its systemic use. As far as the topical use is concerned SP seems to be highly effective with absence of systemic effects. Local mild side effects were present in a small number of patients.
authors: Dipartimento di Fisiopatologia Clinica, Università di Torino, Italy.
authors: M
authors: M
authors: Messina
authors: C
authors: C
authors: Manieri
authors: M C
authors: MC
authors: Musso
authors: R
authors: R
authors: Pastorino
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy; D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000726:Androgen Antagonists / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D008297:Male; D012867:Skin / Q000378:metabolism*; D013148:Spironolactone / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000726:Androgen Antagonists; D013148:Spironolactone